How has been the historical performance of Medplus Health?

Answer:The historical performance of Medplus Health shows a consistent growth trajectory in net sales and profitability over the years.

Breakdown:
Medplus Health has demonstrated significant growth in net sales, increasing from 2,870.60 Cr in March 2020 to 6,136.05 Cr in March 2025. This upward trend reflects a robust annual growth rate, with sales rising from 3,069.27 Cr in March 2021 to 5,624.86 Cr in March 2024. Total operating income has mirrored this growth, reaching 6,136.05 Cr in March 2025. The company's total expenditure has also increased, from 2,736.92 Cr in March 2020 to 5,648.95 Cr in March 2025, but the operating profit has improved significantly, with operating profit (PBDIT) rising from 150.96 Cr in March 2020 to 535.72 Cr in March 2025. Profit before tax has shown a substantial increase, climbing from 29.36 Cr in March 2020 to 183.29 Cr in March 2025, while profit after tax has also risen from 1.79 Cr to 150.23 Cr in the same period. The company's total assets have expanded from 1,308.54 Cr in March 2020 to 3,260.27 Cr in March 2025, indicating a strong financial position. However, total debt has remained at zero since March 2020, showcasing a debt-free status. Cash flow from operating activities has improved significantly, reaching 540.00 Cr in March 2025, while the closing cash and cash equivalents have decreased slightly from 91.00 Cr in March 2024 to 86.00 Cr in March 2025. Overall, Medplus Health has shown a solid performance with increasing revenues, profitability, and a stable balance sheet.